![Meenu Karson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Meenu Karson
Directeur Général chez
Onsero Therapeutics Inc
Profil
Meenu Karson currently works at Onsero Therapeutics Inc, as President & Chief Executive Officer from 2021, Vasomune Therapeutics, Inc., as Director, and Fore Biotherapeutics, Inc., as Director.
Ms. Karson also formerly worked at Allozyne, Inc., as President & Chief Executive Officer from 2007 to 2014, Apexigen, Inc., as Chairman from 2022 to 2023, Vallon Pharmaceuticals, Inc., as Director, BioXell SpA, as Chief Business Officer, and Novartis AG, as VP-Business Development & Licensing.
Ms. Karson received her undergraduate degree from the University of Toronto and Masters Business Admin degree from The Schulich School of Business.
Postes actifs de Meenu Karson
| Sociétés | Poste | Début |
|---|---|---|
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Directeur/Membre du Conseil | - |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops medications for treatment of diseases associated with vascular dysfunction | Directeur/Membre du Conseil | - |
Onsero Therapeutics Inc
 Onsero Therapeutics Inc Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical neurobiology company | Directeur Général | 01/07/2021 |
Anciens postes connus de Meenu Karson
| Sociétés | Poste | Fin |
|---|---|---|
| APEXIGEN, INC. | Président | 23/08/2023 |
| GRI BIOPAR | Directeur/Membre du Conseil | 21/04/2023 |
Allozyne, Inc.
 Allozyne, Inc. Medical SpecialtiesHealth Technology Develops and manufactures pharmaceutical products | Directeur Général | 02/01/2014 |
BioXell SpA
 BioXell SpA BiotechnologyHealth Technology Manufactures drugs for inflammatory diseases | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Formation de Meenu Karson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
35
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
BioXell SpA
BioXell SpA BiotechnologyHealth Technology Manufactures drugs for inflammatory diseases | Health Technology |
Allozyne, Inc.
Allozyne, Inc. Medical SpecialtiesHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Schulich School of Business
 The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops medications for treatment of diseases associated with vascular dysfunction | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Health Technology |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
Onsero Therapeutics Inc
Onsero Therapeutics Inc Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical neurobiology company | Commercial Services |
